Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Exosome Injection for Male Androgenetic Alopecia
NCT07112586Phase 2Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Aug 2025
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in androgenetic alopecia (AGA), sponsored by Ain Shams University. Primary endpoint: Terminal to vellus hair ratio improvement at 1 year. Planned start Aug 2025; status: not yet recruiting.
02
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07112586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07112586.